RespireRx Pharmaceuticals Inc (RSPI)

[NeutrinoKid]

Some news, alternative indication for Respirerx RSPI pipeline, cited as key player.

A condition related to obstructive sleep apnea - exploding head syndrome (really!).

https://www.bigouden.tv/2024/04/23/traitement-du-syndrome-de-la-tete-qui-explose-analyse-du-marche-paysage-concurrentiel-facteurs-de-croissance-revenus-fabre-kramer-pharmaceuticals-jazz-pharmaceutical-merck-co/

“Les principaux acteurs sont également clairement ciblés dans le rapport, avec des faits et des chiffres mentionnés.

• Arena Pharmaceuticals
• Boehringer Ingelheim
• Fabre-Kramer Pharmaceuticals
• Jazz Pharmaceutical
• Merck & Co
• Glaxo Smith Kline
• Respirerx Pharmaceuticals
• Neurocrine Biosciences”

https://www.statsndata.org/report/exploding-head-syndrome-treatment-market-30870

“EXPLODING HEAD SYNDROME TREATMENT MARKET RESEARCH REPORT FOR 2023: EXPLORING FUTURE OPPORTUNITIES, EMERGING TRENDS, COMPREHENSIVE ANALYSIS, AND FORECAST UNTIL 2029

Key Players
Arena Pharmaceuticals
Boehringer Ingelheim
Fabre-Kramer Pharmaceuticals
Jazz Pharmaceutical
Merck & Co
Glaxo Smith Kline
Respirerx Pharmaceuticals
Neurocrine Biosciences”